Barbara Feder Ostrov, Senior Correspondent for California Healthline, has reported on medicine and health policy for more than 15 years. She covered the medical beat for the San Jose Mercury News for eight years and edited the website of the Center for Health Journalism at the USC Annenberg School of Journalism. She previously worked at The Palm Beach Post and the Miami Herald. Her work also has been published in The Boston Globe, Ms. Magazine, Atlantic.com, PBS NewsHour, NPR, CNN.com and EverydayHealth.com. She has won awards from the Society for Women’s Health Research, the California Newspaper Publishers Association and the Florida Press Club. She is based in San Jose, California.
Barbara Feder Ostrov
Kaiser Health News
From this contributor
How the college admissions cheating scandal hurts students with disabilities
In the wake of this week's college admissions cheating scandal, families and advocates are worried about a backlash that could make it harder for students with legitimate disabilities to get the accommodations the need.
How the college admissions cheating scandal hurts students with disabilities
Study of birth defects, folic acid in foods finds more questions than answers
Fortifying cereal and bread products with folic acid has not led to as dramatic a decline in congenital defects as expected.
Study of birth defects, folic acid in foods finds more questions than answers
Explore more from The Transmitter
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.